Interstitial lung disease in polymyositis and dermatomyositis

By Chen I-Jung   Jan Wu Yeong-Jian   Lin Cho-Wei   Fan Kang-Wei   Luo Shue-Fen   Ho Huei-Huang   Liou Lieh-Bang   Tsai Wen-Pin   Chen Ji-Yih   Yang Chung-Han   Kuo Chang-Fu   Yu Kuang-Hui  

Clinical Rheumatology, Vol. 28, Iss. 6, 2009-06 ,pp. : 639-646

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of Interstitial Lung Disease Associated with Polymyositis- Dermatomyositis: An Update

By  

Current Respiratory Medicine Reviews, Vol. 9, Iss. 2, 2013-01 ,pp. : 130-136

Bentham Science Publishers

Access to resources Recommend Favorite

Polymyositis/dermatomyositis associated with acute myelocytic leukemia

By Shen Jia-Kun  

Rheumatology International, Vol. 28, Iss. 12, 2008-10 ,pp. : 1265-1267

Springer Publishing Company

Access to resources Recommend Favorite

Marked increase in serum KL-6 and surfactant protein D levels during the first 4 weeks after treatment predicts poor prognosis in patients with active interstitial pneumonia associated with polymyositis/dermatomyositis

By Arai Satoko   Kurasawa Kazuhiro   Maezawa Reika   Owada Takayoshi   Okada Harutsugu   Fukuda Takeshi  

Modern Rheumatology, Vol. 23, Iss. 5, 2013-09 ,pp. : 872-883

Springer Publishing Company

Access to resources Recommend Favorite

Serum ferritin correlates with activity of anti-MDA5 antibody-associated acute interstitial lung disease as a complication of dermatomyositis

By Gono Takahisa  

Modern Rheumatology, Vol. 21, Iss. 2, 2011-04 ,pp. : 223-227

Springer Publishing Company

Access to resources Recommend Favorite